C

Classys Inc
KOSDAQ:214150

Watchlist Manager
Classys Inc
KOSDAQ:214150
Watchlist
Price: 55 600 KRW -3.3% Market Closed
Market Cap: ₩3.6T

Classys Inc
Cash & Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Classys Inc
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
C
Classys Inc
KOSDAQ:214150
Cash & Cash Equivalents
₩37.5B
CAGR 3-Years
13%
CAGR 5-Years
-10%
CAGR 10-Years
64%
I
I Sens Inc
KOSDAQ:099190
Cash & Cash Equivalents
₩45B
CAGR 3-Years
-10%
CAGR 5-Years
8%
CAGR 10-Years
7%
W
Won Tech Co Ltd
KOSDAQ:336570
Cash & Cash Equivalents
₩32.8B
CAGR 3-Years
445%
CAGR 5-Years
90%
CAGR 10-Years
N/A
V
Viol Co Ltd
KOSDAQ:335890
Cash & Cash Equivalents
₩35.1B
CAGR 3-Years
79%
CAGR 5-Years
77%
CAGR 10-Years
N/A
S
Seers Technology Co Ltd
KOSDAQ:458870
Cash & Cash Equivalents
₩10.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
NextBioMedical Co Ltd
KOSDAQ:389650
Cash & Cash Equivalents
₩5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Classys Inc
Glance View

Market Cap
3.6T KRW
Industry
Health Care

Classys Inc., a South Korean powerhouse in the world of aesthetic medical devices, has carved a niche for itself by capitalizing on the soaring demand for non-invasive beauty treatments. Founded in 2007, the company quickly identified a growing market shift towards minimally invasive procedures, and leveraged its technological prowess to develop cutting-edge solutions. Focusing on continuous innovation, Classys has developed a robust portfolio of high-quality products, including popular devices like Clatuu Alpha for fat reduction and Ultraformer for skin lifting. These devices cater to clinics and professionals seeking reliable, effective solutions for their clients' aesthetic needs. The company strategically invests in research and development to stay ahead in this highly competitive sector, continually upgrading its offerings to suit market trends. Operating in over 60 countries, Classys has effectively harnessed the power of global distribution networks and strategic partnerships to bolster its market presence. The company's business model primarily revolves around direct sales and distribution agreements, generating revenue by selling advanced aesthetic devices to medical professionals, clinics, and distributors worldwide. By providing training and after-sales services, Classys ensures customer satisfaction and fosters long-term relationships, which are crucial for repeat business. Additionally, its strong emphasis on compliance with international safety standards and certifications has bolstered its reputation, enabling the company to expand its footprint in emerging markets. This strategic approach has allowed Classys to maintain steady growth in an industry where technological advancements and consumer preferences are in constant flux.

Intrinsic Value
57 469.23 KRW
Undervaluation 3%
Intrinsic Value
Price ₩55 600
C

See Also

What is Classys Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
37.5B KRW

Based on the financial report for Dec 31, 2025, Classys Inc's Cash & Cash Equivalents amounts to 37.5B KRW.

What is Classys Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
64%

Over the last year, the Cash & Cash Equivalents growth was 65%. The average annual Cash & Cash Equivalents growth rates for Classys Inc have been 13% over the past three years , -10% over the past five years , and 64% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett